methylphenidate has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 5 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The importance of DAT in Parkinson's disease (PD) in which DAT may be reduced by 50 to 70% is unclear." | 2.71 | The dopamine transporter: importance in Parkinson's disease. ( Carter, JH; Nutt, JG; Sexton, GJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oakes, HV | 1 |
| McWethy, D | 1 |
| Ketchem, S | 1 |
| Tran, L | 1 |
| Phillips, K | 1 |
| Oakley, L | 1 |
| Smeyne, RJ | 1 |
| Pond, BB | 1 |
| Zhang, LL | 1 |
| Canning, SD | 1 |
| Wang, XP | 1 |
| GIBERTI, F | 1 |
| GIANNIOTTI, G | 1 |
| SPIZZIRRI, S | 1 |
| Nutt, JG | 1 |
| Carter, JH | 1 |
| Sexton, GJ | 1 |
| Wüllner, U | 1 |
| Reimold, M | 1 |
| Abele, M | 1 |
| Bürk, K | 1 |
| Minnerop, M | 1 |
| Dohmen, BM | 1 |
| Machulla, HJ | 1 |
| Bares, R | 1 |
| Klockgether, T | 1 |
1 review available for methylphenidate and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Freezing of Gait in Parkinsonism and its Potential Drug Treatment.
Topics: Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Botulinum Toxins; Droxidopa; Gait Disorde | 2016 |
1 trial available for methylphenidate and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
The dopamine transporter: importance in Parkinson's disease.
Topics: Aged; Analysis of Variance; Blood Pressure; Dopamine Agents; Dopamine Plasma Membrane Transport Prot | 2004 |
3 other studies available for methylphenidate and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism.
Topics: Animals; Corpus Striatum; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Female; Methylphenidate; | 2021 |
[Further results of new therapy of Parkinsonian syndromes; therapeutic action of 3-phenyl-3-b-diethylamino-ethyl-2-6-dioxy-piperidine hydrochloride administered alone and with reserpine and ritalin].
Topics: Methylphenidate; Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; Piperidines; Reserpi | 1957 |
Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.
Topics: Adult; Binding, Competitive; Biomarkers; Brain; Brain Mapping; Dopamine; Dopamine Plasma Membrane Tr | 2005 |